Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionTownsquare Capital Llc
Latest Disclosed Ownership1,557 shares
Latest Disclosed Value $ 237,832
Townsquare Capital Llc reports 17.79% decrease in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 13, 2026 - Townsquare Capital Llc filed a 13F-HR form disclosing ownership of 1,557 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $237,832 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 3, 2025 disclosing 1,894 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -17.79% during the quarter. The current value of the position is $231,059 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 1,557 -337 -17.79 238 -2.07 0.0536
2025-11-03 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 1,894 -3,966 -67.68 243 -65.87 0.0367
2025-08-13 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 5,860 -84,992 -93.55 709 -93.00 0.0691
2025-05-12 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 90,852 799 0.89 10,128 15.58 0.1079
2025-02-13 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 90,053 47,294 110.61 8,763 78.18 0.0989
2024-11-13 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 42,759 11,866 38.41 4,918 49.57 0.0589
2024-08-14 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 30,893 5,545 21.88 3,289 34.15 0.0449
2024-05-15 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 25,348 10,222 67.58 2,452 60.51 0.0359
2024-02-15 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 15,126 -10,529 -41.04 1,527 -41.56 0.0262
2023-11-15 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 25,655 -2,570 -9.11 2,613 -8.25 0.0477
2023-11-13 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 28,225 14,852 111.06 2,848 131.54 0.0519
2023-05-11 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 13,373 -7,090 -34.65 1,230 -33.73 0.0271
2023-02-13 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 20,463 3,838 23.09 1,856 46.84 0.0459
2022-11-14 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 16,625 -88 -0.53 1,264 -10.54 0.0362
2022-08-08 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 16,713 4,464 36.44 1,413 31.44 0.0401
2022-04-28 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 12,249 3,600 41.62 1,075 42.01 0.0199
2022-02-11 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 8,649 -1,732 -16.68 757 -10.84 0.0190
2021-11-15 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 10,381 4,596 79.45 849 60.19 0.0245
2021-08-16 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 5,785 2,769 91.81 530 105.43 0.0171
2021-05-17 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 3,016 -14,669 -82.95 258 -84.54 0.0100
2021-02-16 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 17,685 441 2.56 1,669 11.94 0.0742
2020-12-01 2020-09-30 13F/A-2 NOVARTIS SPONSORED ADR 66987V109 17,244 4,311 33.33 1,491 33.96 0.0869
2020-11-16 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 12,933 0 1,113 28,306.9470
2020-08-17 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 12,933 4,359 50.84 1,113 55.66 0.0756
2020-05-18 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 8,574 -3,027 -26.09 715 -34.94 0.0578
2020-05-18 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 11,601 -215 -1.82 1,099 6.91 0.0892
2019-11-14 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 11,816 2,290 24.04 1,028 17.08 0.0850
2019-08-15 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 9,526 503 5.57 878 1.15 0.0836
2019-05-15 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 9,023 5,184 135.04 868 154.55 0.0670
2019-02-12 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,839 3,839 341 0.0444
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.